India Pharmaceutical Forum 2017

Session 2 : Reflections on Journey So Far- Vikas Bhadoria, McKinsey &amp; Co

Session 2 : Release of IPA Data Reliability Guidelines

Session 3 : EMA&#039;s Guidance on Data Integrity- Brendan Cuddy, EMA

Session 4 : India&#039;s Regulatory Reforms- V G Somani, CDSCO

Session 4 : India&#039;s Regulatory Reforms- R Chandrashekar, CDSCO

Session 4 : India&#039;s Regulatory Reforms: Patient Safety- V G Somani, CDSCO

Session 5 : Building a Strong Quality Culture and Line Ownership- Alicia Mozzachio, USFDA

Session 5 : Building a Strong Quality Culture and Line Ownership- Gerald Heddell, MHRA

Session 6 : Batch Failure Investigation- Alicia Mozzachio, USFDA and Mark Birse, MHRARead More

Session 7 : Complaints - Investigation &amp; Review- Mathew T Thomas, USFDA

Session 8 : Compliance Trends- Paula Katz, USFDA

Session 8 : Compliance Trends- Mark Birse, MHRA

Session 9: How to Benefit from EDQM Inspections- Caroline Le Tarnec, EDQM

Session 10: Quality Metrics- Paula Katz, USFDA

Session 10: Quality Metrics- Brendan Cuddy, EMA